| Field | Specification |
|---|---|
| UniProt # | |
| Applications | |
| Sensitivity | |
| Detection range | |
| Detection method | |
| Assay time | |
| Storage | |
| Shipping | |
| Catalog no. (Mfr.) | |
| Main SKU |
Scientific Background
This ELISA kit applies to the in vitro quantitative determination of Human PⅢNP concentrations in serum, plasma and other biological fluids.
Assay Principle
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human PⅢNP. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human PⅢNP and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human PⅢNP, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human PⅢNP. You can calculate the concentration of Human PⅢNP in the samples by comparing the OD of the samples to the standard curve.
Performance Specifications
| Sensitivity | 14.06 pg/mL |
|---|---|
| Detection Range | 23.44-1500 pg/mL |
| Total Assay Time | 3 h 30 min |
| Compatible Sample Types | Serum, plasma and other biological fluids |
| Species Reactivity | Human |
| Detection Method | Sandwich |
| Precision (CV) | Both intra-CV and inter-CV are < 10%. |
| Recovery Rate | 80%-120% |
| Storage | 2-8℃,12 months |
✓ Research-Grade Validation
Specificity
This kit recognizes Human PⅢNP in samples. No significant cross-reactivity or interference between Human PⅢNP and analogues was observed
Safety & Regulatory
Handle reagents in accordance with institutional biosafety guidelines. Refer to the Safety Data Sheet (SDS) for complete hazard and handling information. Contains components that may require special disposal procedures per local regulations.
This kit is validated for use with Serum, plasma and other biological fluids. For unlisted matrices (e.g., tissue lysate, urine), perform a spike-and-recovery experiment to confirm assay performance before generating reportable data. Sample dilution in the kit's provided diluent is recommended to minimize matrix interference.
The minimum detectable concentration (sensitivity) of this kit is 14.06 pg/mL. Values below this threshold should be reported as below the limit of detection (<LOD) and should not be extrapolated from the standard curve.
The total assay time from sample addition to absorbance reading is approximately 3 h 30 min, including all incubation, wash, and substrate steps. Hands-on time is typically 1–2 hours; most steps involve passive plate incubation. Plan the assay as a single uninterrupted session for best results.
Standard components of this Sandwich ELISA Kit typically include: pre-coated microplate (96-well strip format), lyophilized or liquid recombinant PⅢNP standard, detection antibody, streptavidin-HRP conjugate, TMB substrate, stop solution, wash buffer concentrate, and sample/standard diluent. Refer to the kit insert or datasheet for the exact component list and storage requirements.
This kit uses colorimetric (TMB/HRP) detection and requires a standard microplate absorbance reader capable of measuring at 450 nm. A reference wavelength of 570 nm or 630 nm is recommended to reduce background. No specialized fluorescence or luminescence reader is needed. Ensure the instrument is calibrated and the plate is clean and free of condensation before reading.
Tissue samples may contain endogenous or exogenous proteases during processing, leading to degradation of extracted proteins. Therefore, it's necessary to add protease inhibitors during processing to ensure the integrity of target proteins. If customers can keep samples cold and handle them quickly during processing, omitting the protease inhibitor may not have a significant effect. After preparation, samples should be tested promptly or immediately aliquoted and frozen at -20°C or -80°C.
What is the range of enzyme activity of your IL-2 freeze-dried powder
What is the principle of adding stop solution to stop color reaction in ELISA experiment?
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
High variability in assays of blood markers of collagen turnover in cardiovascular disease: Implications for research and clinical practice (2024) EUROPEAN JOURNAL OF HEART FAILURE. 10.1002/ejhf.3375
No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial (2016) BMC Medicine. 10.1186/s12916-016-0638-y
Imaging, biomarker and invasive assessment of diffuse left ventricular myocardial fibrosis in atrial fibrillation (2020) JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE. 10.1186/s12968-020-0603-y
Circulating Biomarkers as Potential Risk Factors for Inguinal Hernia (2025) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 10.3390/ijms26157032
Associations between serum ghrelin and knee symptoms, joint structures and cartilage or bone biomarkers in patients with knee osteoarthritis (2017) OSTEOARTHRITIS AND CARTILAGE. 10.1016/j.joca.2017.05.015
Intra-cardiac and peripheral levels of biochemical markers of fibrosis in patients undergoing catheter ablation for atrial fibrillation (2017) EUROPACE. 10.1093/europace/euw315
Micro-fragmented adipose tissue (mFAT) associated with arthroscopic debridement provides functional improvement in knee osteoarthritis: a randomized controlled trial (2022) KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY. 10.1007/s00167-022-07101-4
The Role of Circulating Collagen Turnover Biomarkers and Late Gadolinium Enhancement in Patients with Non-Ischemic Dilated Cardiomyopathy (2022) Diagnostics. 10.3390/diagnostics12061435
The evaluation of the tendon and muscle changes of lower extremity in patients with acromegaly (2020) Pituitary. 10.1007/s11102-020-01037-z
Procollagen-III peptide identifies adipose tissue-associated inflammation in type 2 diabetes with or without nonalcoholic liver disease (2018) DIABETES-METABOLISM RESEARCH AND REVIEWS. 10.1002/dmrr.2998
Driving pressure and long-term outcomes in moderate/severe acute respiratory distress syndrome (2018) Annals of Intensive Care. 10.1186/s13613-018-0469-4
Direct actions of dapagliflozin and interactions with LCZ696 and spironolactone on cardiac fibroblasts of patients with heart failure and reduced ejection fraction (2022) ESC Heart Failure. 10.1002/ehf2.14186
On-treatment monitoring of liver fibrosis with serum hepatitis B core-related antigen in chronic hepatitis B (2019) WORLD JOURNAL OF GASTROENTEROLOGY. 10.3748/wjg.v25.i32.4764
Elevated β1-Adrenergic Receptor Autoantibody Levels Increase Atrial Fibrillation Susceptibility by Promoting Atrial Fibrosis (2020) Frontiers in Physiology. 10.3389/fphys.2020.00076
Lumenato protects normal human dermal fibroblasts from neutrophil-induced collagen-3 damage in co-cultures (2021) PLoS One. 10.1371/journal.pone.0248183
Utility of Serum Biomarkers of Myocardial Fibrosis in High-Gradient Severe Aortic Stenosis: An Explorative Cardiovascular Magnetic Resonance Imaging-Based Study (2025) Diagnostics. 10.3390/diagnostics15091143
Left atrial voltage, circulating biomarkers of fibrosis, and atrial fibrillation ablation. A prospective cohort study (2018) PLoS One. 10.1371/journal.pone.0189936
Circulating biomarkers of fibrosis and cardioversion of atrial fibrillation: A prospective, controlled cohort study (2016) CLINICAL BIOCHEMISTRY. 10.1016/j.clinbiochem.2016.09.008
Effect of DAPAgliflozin on Myocardial Fibrosis and Ventricular Function in Patients with ST-Segment Elevation Myocardial Infarction—DAPA-STEMI Trial (2025) Journal of Cardiovascular Development and Disease. 10.3390/jcdd12060220
Associations between serum IL-8 and knee symptoms, joint structures, and cartilage or bone biomarkers in patients with knee osteoarthritis (2019) CLINICAL RHEUMATOLOGY. 10.1007/s10067-019-04718-8
Association between serum cytokeratin 18 and N-terminal procollagen III propeptide in patients with biopsy-proven nonalcoholic fatty liver disease* (2024) BIOTECHNIC & HISTOCHEMISTRY. 10.1080/10520295.2024.2385011
Monocyte Chemoattractant Protein-1-Induced Protein in Age-Related Atrial Fibrillation and Its Association with Circulating Fibrosis Biomarkers (2019) CARDIOLOGY. 10.1159/000499932
